Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Oruka Therapeutics, Inc.Listing on record | Sell | $234.7K | SEC | |
Oruka Therapeutics, Inc.Listing on record | Sell | $443.7K | SEC | |
Oruka Therapeutics, Inc.Listing on record | Sell | $5.8M | SEC | |
Oruka Therapeutics, Inc.Listing on record | Sell | $599.6K | SEC | |
Oruka Therapeutics, Inc.Listing on record | Exercise | $585K | SEC | |
Oruka Therapeutics, Inc.Listing on record | ExerciseD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | Sell | $120.5K | SEC | |
Jade Biosciences, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | Sell | $71.4K | SEC | |
Oruka Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | Award | — | SEC | |
Jade Biosciences, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Oruka Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Jasper Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Jasper Therapeutics, Inc.Listing on record | Award | — | SEC | |
CRISPR Therapeutics AGListing on record | AwardD (derivative) | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Jasper Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
CRISPR Therapeutics AGListing on record | Other | $75.1K | SEC | |
CRISPR Therapeutics AGListing on record | Exercise | — | SEC | |
CRISPR Therapeutics AGListing on record | Exercise | — | SEC | |
CRISPR Therapeutics AGListing on record | ExerciseD (derivative) | — | SEC | |
CRISPR Therapeutics AGListing on record | ExerciseD (derivative) | — | SEC | |
CRISPR Therapeutics AGListing on record | Other | $117.8K | SEC |